Welcome to the Edwards live portal, showcasing the latest on transcatheter mitral & tricuspid therapies
In collaboration with cardiologists like you, our transcatheter mitral and tricuspid therapies are making a meaningful mark on the lives of patients with mitral regurgitation (MR) and tricuspid regurgitation (TR).
Explore this portal to find learnings from each congress, and stay up to date with the latest news, evidence and Edwards innovation in MR and TR treatment for your patients.
The latest innovation on transcatheter mitral and tricuspid therapies
Download every edition of TMTT Today for free, featuring expert insight and the latest data on transcatheter mitral and tricuspid therapies.
Get Edwards updates
Be the first to hear about the latest Edwards news, evidence and future events by joining our mailing list today.
Can we help?
If you have any questions or would like to speak to an Edwards representative, you can begin by following the link below.
MR, mitral regurgitation; TR, tricuspid regurgitation.
Medical device for professional use. For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult eifu.edwards.com where applicable).